BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38836837)

  • 1. Phospholipid metabolism-related genotypes of PLA2R1 and CERS4 contribute to nonobese MASLD.
    Shao C; Ye J; Dong Z; Liao B; Feng S; Hu S; Zhong B
    Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38836837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between m-type phospholipase A2 receptor,human leukocyte antigen gene polymorphisms and idiopathic membranous nephropathy.
    Liu X; Xu W; Yu C; Wang M; Liu R; Xie R
    Bioengineered; 2021 Dec; 12(1):8833-8844. PubMed ID: 34607530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of SNPs in
    Tian CX; Li L; Qiu P; Qiu YR
    Br J Biomed Sci; 2020 Jan; 77(1):24-28. PubMed ID: 31532353
    [No Abstract]   [Full Text] [Related]  

  • 4. PLA2R-associated membranous glomerulopathy is modulated by common variants in PLA2R1 and HLA-DQA1 genes.
    Saeed M; Beggs ML; Walker PD; Larsen CP
    Genes Immun; 2014 Dec; 15(8):556-61. PubMed ID: 25187357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-nucleotide polymorphism rs4664308 in PLA2R1 gene is associated with the risk of idiopathic membranous nephropathy: a meta-analysis.
    Yoshikawa M; Asaba K
    Sci Rep; 2020 Aug; 10(1):13119. PubMed ID: 32753608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of PLA2R1 and HLA-DQA1 sequence variants in Japanese patients with idiopathic and secondary membranous nephropathy.
    Kaga H; Komatsuda A; Omokawa A; Okuyama S; Mori K; Wakui H; Takahashi N
    Clin Exp Nephrol; 2018 Apr; 22(2):275-282. PubMed ID: 28849274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between PLA2R1 and HLA-DQA1 variants contributes to the increased genetic susceptibility to membranous nephropathy in Western China.
    Wang W; Fan S; Li G; Wang AY; Hong D; Zhong X; Wang L
    Nephrology (Carlton); 2019 Sep; 24(9):919-925. PubMed ID: 30467913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan.
    Liu YH; Chen CH; Chen SY; Lin YJ; Liao WL; Tsai CH; Wan L; Tsai FJ
    J Biomed Sci; 2010 Oct; 17(1):81. PubMed ID: 20937089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy.
    Coenen MJ; Hofstra JM; Debiec H; Stanescu HC; Medlar AJ; Stengel B; Boland-Augé A; Groothuismink JM; Bockenhauer D; Powis SH; Mathieson PW; Brenchley PE; Kleta R; Wetzels JF; Ronco P
    J Am Soc Nephrol; 2013 Mar; 24(4):677-83. PubMed ID: 23431073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLA2R1 and HLA-DQA1 gene variations in idiopathic membranous nephropathy in South China.
    Wang F; Wang TT; Liang XW; Lu JD; Xie QH; Chen RY; Xue J
    Ann Acad Med Singap; 2021 Jan; 50(1):33-41. PubMed ID: 33623956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.
    Bullich G; Ballarín J; Oliver A; Ayasreh N; Silva I; Santín S; Díaz-Encarnación MM; Torra R; Ars E
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):335-43. PubMed ID: 24262501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians.
    Ramachandran R; Kumar V; Kumar A; Yadav AK; Nada R; Kumar H; Kumar V; Rathi M; Kohli HS; Gupta KL; Sakhuja V; Jha V
    Nephrol Dial Transplant; 2016 Sep; 31(9):1486-93. PubMed ID: 26673907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-nucleotide polymorphisms in the PLA2R1 gene are associated with systemic lupus erythematosus and lupus nephritis in a Chinese Han population.
    Li Y; Zhou A; Lv G; Li P; Chen S; Li J; Wen X; Wu Z; Zhang S; Wang J; Zhang F; Li Y
    Immunol Res; 2016 Feb; 64(1):324-8. PubMed ID: 26645973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay of Mediterranean-diet adherence, genetic factors, and metabolic dysfunction-associated steatotic liver disease risk in Korea.
    Kwon YJ; Choi JE; Hong KW; Lee JW
    J Transl Med; 2024 Jun; 22(1):591. PubMed ID: 38918799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride to HDL Cholesterol Ratio for the Identification of MASLD in Obesity: A Liver Biopsy-Based Case-Control Study.
    Martínez-Montoro JI; Martínez-Sánchez MA; Balaguer-Román A; Fernández-Ruiz VE; Hernández-Barceló JE; Ferrer-Gómez M; Frutos MD; Núñez-Sánchez MÁ; Fernández-García JC; Ramos-Molina B
    Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy.
    Lv J; Hou W; Zhou X; Liu G; Zhou F; Zhao N; Hou P; Zhao M; Zhang H
    J Am Soc Nephrol; 2013 Jul; 24(8):1323-9. PubMed ID: 23813219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy.
    Kim S; Chin HJ; Na KY; Kim S; Oh J; Chung W; Noh JW; Lee YK; Cho JT; Lee EK; Chae DW;
    Nephron Clin Pract; 2011; 117(3):c253-8. PubMed ID: 20805699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipidomic Analysis Reveals Alterations in Hepatic FA Profile Associated With MASLD Stage in Patients With Obesity.
    Núñez-Sánchez MÁ; Martínez-Sánchez MA; Martínez-Montoro JI; Balaguer-Román A; Murcia-García E; Fernández-Ruiz VE; Ferrer-Gómez M; Martínez-Cáceres CM; Sledzinski T; Frutos MD; Hernández-Morante JJ; Fernández-García JC; Queipo-Ortuño MI; Ruiz-Alcaraz AJ; Mika A; Ramos-Molina B
    J Clin Endocrinol Metab; 2024 Jun; 109(7):1781-1792. PubMed ID: 38217869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between PLA2R1 rs4664308 and susceptibility to idiopathic membranous nephropathy: Protocol for a systematic review and meta-analysis of case-control studies.
    Qiu JY; Wu XG; Zhang T; Park S
    Medicine (Baltimore); 2020 Nov; 99(45):e22908. PubMed ID: 33157933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice.
    Zou Z; Liu X; Yu J; Ban T; Zhang Z; Wang P; Huang R; Zheng F; Chang Y; Peng W; Tang Y; Feng X; Zhao Z; Lv X; Huang S; Guo J; Tuo Y; Zhou Z; Liang S
    J Hepatol; 2024 Jun; 80(6):834-845. PubMed ID: 38331323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.